Impaired GNE function, rather than lack of expression, is likely the key pathogenic factor in HIBM, meaning diagnosis requires direct genetic analysis rather than protein staining.
Answers are grounded in this paper and cite their sources.
Equal GNE expression in HIBM does not support expression-targeted therapies; leaves open functional impairment mechanisms for study.
Mutations in GNE encoding UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) cause hereditary inclusion body myopathy (HIBM). To define the role of GNE mutations in HIBM pathogenesis, GNE protein expression was analyzed. GNE protein is expressed at equal levels in HIBM patients and normal control subjects. Immunofluorescence detection of GNE did not reveal any mislocalization of GNE in skeletal muscle. We conclude that impaired GNE function, not lack of expression, may be the key pathogenic factor in HIBM. For diagnostic purposes, direct genetic analysis of the GNE gene in patients with IBM will remain the mainstay and is not aided by immunohistochemistry or immunoblotting using antibodies against the GNE protein.
No takes yet. Share an insight, caveat, or question.
Krause et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: